Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 17:14:42 UTC |
---|
Update Date | 2021-09-26 23:12:33 UTC |
---|
HMDB ID | HMDB0256694 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Pomalidomide |
---|
Description | Pomalidomide, also known as pomalyst or CC 4047, belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. Based on a literature review a significant number of articles have been published on Pomalidomide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Pomalidomide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Pomalidomide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) |
---|
Synonyms | Value | Source |
---|
3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide | ChEBI | 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione | ChEBI | 4-Aminothalidomide | ChEBI | CC 4047 | ChEBI | CC-4047 | ChEBI | Pomalyst | ChEBI | S-3-amino-phthalimido-Glutarimide | MeSH | 3-Aminophthalimidoglutarimide | MeSH | S-3APG | MeSH | 3-aminio-phthalimido-Glutarimide | MeSH |
|
---|
Chemical Formula | C13H11N3O4 |
---|
Average Molecular Weight | 273.2441 |
---|
Monoisotopic Molecular Weight | 273.074955855 |
---|
IUPAC Name | 4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione |
---|
Traditional Name | pomalidomide |
---|
CAS Registry Number | Not Available |
---|
SMILES | NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O |
---|
InChI Identifier | InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) |
---|
InChI Key | UVSMNLNDYGZFPF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Isoindoles and derivatives |
---|
Sub Class | Isoindolines |
---|
Direct Parent | Phthalimides |
---|
Alternative Parents | |
---|
Substituents | - Phthalimide
- Alpha-amino acid or derivatives
- Isoindole
- Piperidinedione
- Delta-lactam
- Piperidinone
- Benzenoid
- Piperidine
- Carboxylic acid imide, n-substituted
- Carboxylic acid imide
- Dicarboximide
- Vinylogous amide
- Carboxylic acid imide, n-unsubstituted
- Amino acid or derivatives
- Lactam
- Carboxylic acid derivative
- Azacycle
- Primary amine
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Carbonyl group
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Pomalidomide,1TMS,isomer #1 | C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | 2841.2 | Semi standard non polar | 33892256 | Pomalidomide,1TMS,isomer #1 | C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | 2838.0 | Standard non polar | 33892256 | Pomalidomide,1TMS,isomer #1 | C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | 4437.5 | Standard polar | 33892256 | Pomalidomide,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O | 2684.2 | Semi standard non polar | 33892256 | Pomalidomide,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O | 2624.6 | Standard non polar | 33892256 | Pomalidomide,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O | 4136.4 | Standard polar | 33892256 | Pomalidomide,2TMS,isomer #1 | C[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C | 2682.7 | Semi standard non polar | 33892256 | Pomalidomide,2TMS,isomer #1 | C[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C | 2882.1 | Standard non polar | 33892256 | Pomalidomide,2TMS,isomer #1 | C[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C | 4084.8 | Standard polar | 33892256 | Pomalidomide,2TMS,isomer #2 | C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C)C1=O)C2=O | 2715.4 | Semi standard non polar | 33892256 | Pomalidomide,2TMS,isomer #2 | C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C)C1=O)C2=O | 2831.7 | Standard non polar | 33892256 | Pomalidomide,2TMS,isomer #2 | C[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C)C1=O)C2=O | 3716.4 | Standard polar | 33892256 | Pomalidomide,3TMS,isomer #1 | C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C)[Si](C)(C)C)=C3C2=O)C1=O | 2583.7 | Semi standard non polar | 33892256 | Pomalidomide,3TMS,isomer #1 | C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C)[Si](C)(C)C)=C3C2=O)C1=O | 2907.0 | Standard non polar | 33892256 | Pomalidomide,3TMS,isomer #1 | C[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C)[Si](C)(C)C)=C3C2=O)C1=O | 3417.6 | Standard polar | 33892256 | Pomalidomide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | 3077.1 | Semi standard non polar | 33892256 | Pomalidomide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | 3057.5 | Standard non polar | 33892256 | Pomalidomide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O | 4349.4 | Standard polar | 33892256 | Pomalidomide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O | 2921.4 | Semi standard non polar | 33892256 | Pomalidomide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O | 2819.9 | Standard non polar | 33892256 | Pomalidomide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N)=C3C2=O)C1=O | 4088.5 | Standard polar | 33892256 | Pomalidomide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C(C)(C)C | 3145.1 | Semi standard non polar | 33892256 | Pomalidomide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C(C)(C)C | 3275.3 | Standard non polar | 33892256 | Pomalidomide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)[Si](C)(C)C(C)(C)C | 3999.2 | Standard polar | 33892256 | Pomalidomide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C(C)(C)C)C1=O)C2=O | 3125.0 | Semi standard non polar | 33892256 | Pomalidomide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C(C)(C)C)C1=O)C2=O | 3229.6 | Standard non polar | 33892256 | Pomalidomide,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)N([Si](C)(C)C(C)(C)C)C1=O)C2=O | 3678.2 | Standard polar | 33892256 | Pomalidomide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C2=O)C1=O | 3244.5 | Semi standard non polar | 33892256 | Pomalidomide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C2=O)C1=O | 3475.1 | Standard non polar | 33892256 | Pomalidomide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CCC(N2C(=O)C3=CC=CC(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3C2=O)C1=O | 3533.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Pomalidomide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0gej-4980000000-d041e1fb3b612b5f8e22 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pomalidomide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pomalidomide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Pomalidomide LC-ESI-qTof , Positive-QTOF | splash10-0udi-1590000000-a511655f5e07f3ab2179 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pomalidomide , positive-QTOF | splash10-0udi-1590000000-a511655f5e07f3ab2179 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pomalidomide 10V, Positive-QTOF | splash10-05fr-0090000000-7d14af32a1640f645afc | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pomalidomide 20V, Positive-QTOF | splash10-0ab9-0190000000-734f84ec8cd642684084 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pomalidomide 40V, Positive-QTOF | splash10-0f76-8940000000-362915b4187ee23f2fcf | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pomalidomide 10V, Negative-QTOF | splash10-00di-0190000000-c438caf9103271bcb665 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pomalidomide 20V, Negative-QTOF | splash10-0h90-1390000000-eb3387d4568613b0761f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pomalidomide 40V, Negative-QTOF | splash10-03dl-9700000000-b666e9e333f7bcb1b3c5 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-27 | Wishart Lab | View Spectrum |
|
---|